Bickling Financial Services, Inc. Abbott Laboratories Transaction History

Bickling Financial Services, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $816 - $986	8 Added 0.36%	2,230 $242,000
Q1 2022 May 25, 2022	BUY	$114.02 - $139.04 $684 - $834	6 Added 0.27%	2,222 $263,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $256,014 - $313,475	2,216 New	2,216 $312,000
Q3 2021 Nov 01, 2021	SELL	$116.66 - $129.06 $408,659 - $452,097	-3,503 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $92,989 - $109,461	879 Added 33.5%	3,503 $406,000
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $285,596 - $336,475	2,624 New	2,624 $314,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Bickling Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Bickling Financial Services, Inc. with notifications on news.